CD274 and neoplasm: Amplifying autophagy in residual tumor cells using targeted nanoparticles enhances immunogenic cell death and anti-tumor immunity, presenting a novel strategy to combat tumor recurrence and resistance to anti-PD-1/PDL1 therapy post-incomplete radiofrequency ablation.